Literature DB >> 11432798

Early antibiotic treatment and later asthma.

M Wjst1, B Hoelscher, C Frye, H E Wichmann, S Dold, J Heinrich.   

Abstract

The reasons for the asthma epidemic are poorly understood. As the asthma prevalence follows the geographical and temporal trend of antibiotic use into clinical medicine, we examined a possible association in a population-based study of 2,512 children age 5-14 in East Germany. Wheezing was associated with increasing number of antibiotic courses (never versus one time odds ratio 1.9, P = 0.012, 2 to 5 times odds ratio 3.0, P<0.001 and more than 5 times, odds ratio 6.9, P<0.001) which was also seen for asthma diagnosis. The risk increased with earlier administration (never versus second year odds ratio 4.6, month 7-12 odds ratio 5.4 and birth until month 6 odds ratio 7.9, all P<0.001). Also non pulmonary treatment indication was associated with later wheezing (odds ratio 3.9, P<0.001). The most likely possible explanation is reverse causation indicating that frequent upper respiratory infections, an early symptom of asthma, are treated with antibiotics. Antibiotic therapy could also be a proxy of another closely associated genetic or environmental factor. The high dose effect, the time dependency of the administration and the effect by non-pulmonary indications raises the possibility that early antibiotic treatment could itself be related to later asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432798

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  15 in total

1.  Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood.

Authors:  Catherine Cohet; Soo Cheng; Claire MacDonald; Michael Baker; Sunia Foliaki; Nyk Huntington; Jeroen Douwes; Neil Pearce
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

Review 2.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

3.  Wheezing and asthma may be enhanced by broad spectrum antibiotics used in early childhood. Concept and results of a pharmacoepidemiology study.

Authors:  W Jedrychowski; F Perera; U Maugeri; E Mroz; E Flak; M Perzanowski; R Majewska
Journal:  J Physiol Pharmacol       Date:  2011-04       Impact factor: 3.011

4.  Dose, Timing, and Type of Infant Antibiotic Use and the Risk of Childhood Asthma.

Authors:  Brittney M Donovan; Andrew Abreo; Tan Ding; Tebeb Gebretsadik; Kedir N Turi; Chang Yu; Juan Ding; William D Dupont; Cosby A Stone; Tina V Hartert; Pingsheng Wu
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

5.  Relation of early antibiotic use to childhood asthma: confounding by indication?

Authors:  Y Su; J Rothers; D A Stern; M Halonen; A L Wright
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

6.  Treatment with Distinct Antibiotic Classes Causes Different Pulmonary Outcomes on Allergic Airway Inflammation Associated with Modulation of Symbiotic Microbiota.

Authors:  Gregório Grama Cavalcante; Anna Gabriella Guimarães; Camila Pereira Queiroz-Glauss; Marcela Helena Gonçalves Pereira; Angélica Samer Lallo Dias; Laila Sampaio Horta; Jamil Silvano de Oliveira; Silvia Dantas Cangussú; Paula Prazeres Magalhães; Remo Castro Russo; H C Santiago
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

7.  Role of antibiotics and fungal microbiota in driving pulmonary allergic responses.

Authors:  Mairi C Noverr; Rachael M Noggle; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 8.  Microbial regulation of allergic responses to food.

Authors:  Taylor Feehley; Andrew T Stefka; Severine Cao; Cathryn R Nagler
Journal:  Semin Immunopathol       Date:  2012-09-01       Impact factor: 9.623

Review 9.  The case of drug causation of childhood asthma: antibiotics and paracetamol.

Authors:  Konrad Heintze; Karl-Uwe Petersen
Journal:  Eur J Clin Pharmacol       Date:  2013-01-05       Impact factor: 2.953

Review 10.  The microbiome of the lung.

Authors:  James M Beck; Vincent B Young; Gary B Huffnagle
Journal:  Transl Res       Date:  2012-02-28       Impact factor: 10.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.